Life sciences and drug discovery
Screen thousands of compounds and targets in code before the lab.
Antinuous scores large compound libraries against a target in parallel and builds target cases from papers, ChEMBL and trial registries. Predicted scores are labeled, and each fact links to its source.
Use cases
Build a case for a drug target
Genetics, biology and trial records sit in many sources, and the review is hard to audit.
You ask
Make a target dossier for LRRK2 in Parkinson's disease: genetic evidence, protein structure, known compounds, and every clinical trial so far.
What it does
- Searches PubMed, NCBI Gene and UniProt for the gene's function and disease links.
- Reads the key papers in full and follows their citations to earlier work.
- Adds structures from PDB and AlphaFold, known compounds from ChEMBL and trials from ClinicalTrials.gov.
- Checks each fact against its source before it lands in the sheet.
You get
A sheet with one cited row per finding and a 3D structure view.
Evidence for a target comes from several linked sources.
Who it's for
Medicinal chemistsScreen compounds against ChEMBL and PubChem data before you buy.
Target biologistsCollect cited evidence for a drug target in one sheet.
Protein engineersView RCSB PDB and AlphaFold structures beside your evidence.
Competitive intelligence analystsTrack competitor programs and trial results on a schedule.
Works with
PubMed
UniProt
RCSB PDB
AlphaFold DB
ChEMBL
ClinicalTrials.gov